I am a
Home I AM A Search Login

Papers of the Week


2022


Front Immunol


13

Case report: bullous pemphigoid development underlies dystrophic epidermolysis bullosa disease worsening.

Authors

Di Zenzo G, Floriddia G, Rossi S, Mariotti F, Primerano A, Condorelli A G, Didona B, Castiglia D
Front Immunol. 2022; 13:929286.
PMID: 35967298.

Abstract

Autoimmune response to cutaneous basement membrane components superimposed on a genetic skin fragility disease, hereditary epidermolysis bullosa (EB), has been described, but its effects on disease course remain unclear. We report a 69-year-old individual with congenital skin fragility and acral trauma-induced blistering that had suddenly worsened with the onset of severe itch and diffuse spontaneous inflammatory blisters. Next-generation sequencing identified compound heterozygous null and missense mutations, allowing the diagnosis of recessive dystrophic EB. However, the patient's clinical history prompted us to investigate whether he might have developed a pathological autoimmune response against basement membrane components. Tissue-bound and circulating IgG antibodies to the major bullous pemphigoid (BP) antigen, BP180, were detected in the patient's skin and serum, respectively, consistent with a diagnosis of BP. Corticosteroid therapy was initiated resulting in remission of BP manifestations. EB patients presenting rapid disease worsening should be investigated for the development of a concomitant autoimmune blistering disease.